| Literature DB >> 35061893 |
Oriana Miltiadous1, Nicholas R Waters2, Hana Andrlová2, Anqi Dai2, Chi L Nguyen2, Marina Burgos da Silva2, Sarah Lindner2, John Slingerland2, Paul Giardina2, Annelie Clurman2, Gabriel K Armijo2, Antonio L C Gomes2, Madhavi Lakkaraja1,3, Peter Maslak4,5,6, Michael Scordo6,7, Roni Shouval7, Anna Staffas8,9, Richard O'Reilly10, Ying Taur6,11, Susan Prockop3,10, Jaap Jan Boelens3,10, Sergio Giralt6,7, Miguel-Angel Perales6,7, Sean M Devlin12, Jonathan U Peled6,7, Kate A Markey6,7,13,14, Marcel R M van den Brink2,6,7.
Abstract
Low intestinal microbial diversity is associated with poor outcomes after allogeneic hematopoietic cell transplantation (HCT). Using 16S rRNA sequencing of 2067 stool samples and flow cytometry data from 2370 peripheral blood samples drawn from 894 patients who underwent allogeneic HCT, we have linked features of the early post-HCT microbiome with subsequent immune cell recovery. We examined lymphocyte recovery and microbiota features in recipients of both unmodified and CD34-selected allografts. We observed that fecal microbial diversity was an independent predictor of CD4 T-cell count 3 months after HCT in recipients of a CD34-selected allograft, who are dependent on de novo lymphopoiesis for their immune recovery. In multivariate models using clinical factors and microbiota features, we consistently observed that increased fecal relative abundance of genus Staphylococcus during the early posttransplant period was associated with worse CD4 T-cell recovery. Our observations suggest that the intestinal bacteria, or the factors they produce, can affect early lymphopoiesis and the homeostasis of allograft-derived T cells after transplantation.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35061893 PMCID: PMC9074404 DOI: 10.1182/blood.2021014255
Source DB: PubMed Journal: Blood ISSN: 0006-4971 Impact factor: 25.476